Protalix BioTherapeutics, Inc (PLX) - Year-over-year net earnings per share growth for the last 12 months

Brandmark of Protalix (PLX)

Protalix BioTherapeutics attracts experts in innovative plant-based protein expression. The team of biologists is developing unique medicines supported by stable R&D funding, while the contractual inertia of enzyme production ensures a steady cash flow. Quarterly EPS variability in the GURU.Markets chart data demonstrates a financial trajectory where 2192.00 determines the current magnitude of the capital efficiency metric.

protalix.com (PLX) Year-over-year net earnings per share trend for the last twelve months: for the period 07/04/2022 - 11/10/2026

PLX (Protalix BioTherapeutics, Inc): analytical breakdowns and indicator data

- share price and expert price forecast:
Stock Price Protalix BioTherapeutics, Inc.|PLX - Broker Consensus Forecast
- market capitalization indicators:
Market Valuation Protalix|PLX - Value Adjusted for Debt and Cash
- book capitalization indicators:
Net Assets per Single Share Protalix BioTherapeutics|PLX - Net Asset Value|Market Capitalization to Book Value Ratio protalix.com|PLX - Aggregate Asset Value
- business debt structure and liquidity details:
Total Debt to Capital Protalix BioTherapeutics|PLX - Long-Term Debt to Capital|Short-Term Debt to Equity Protalix BioTherapeutics|PLX - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Protalix|PLX - Company Long-Term Liabilities|Company Short-Term Debts Protalix BioTherapeutics|Quick Liquidity protalix.com
- earnings and market multiples details:
PLX - Profit After Tax|Expected Profit Protalix BioTherapeutics|PLX - Company Value to Net Income|Future Price to Earnings Protalix|PLX - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio Protalix|PLX - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) Protalix BioTherapeutics|PLX - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months protalix.com|PLX - Earnings per share growth in current year|Earnings growth forecast for next year Protalix BioTherapeutics
Summary company analytics:Protalix BioTherapeutics
Flagship merchandise of Protalix BioTherapeutics

This indicator captures the dynamics of net earnings per share, reflecting the real value of fundamental shifts in the business. The metric allows investors to filter out market noise by discounting future expectations through the lens of actual yield. By analyzing quarterly earnings per share (EPS) growth, an investor assesses capital stability. For Protalix BioTherapeutics (PLX), this figure confirms the production efficiency of plant-based enzymes. Stable contract payments ensure predictable profit growth.

Main competitors

VRTX: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months ALNY|Year-over-year net earnings per share growth for the last 12 months INSM|UTHR: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months BioMarin Pharmaceutical (BMRN)|BBIO: Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth BGM (BGM Group)|Year-over-year earnings per one share growth for the last 12 months COGT|Xeris Biopharma Inc - Quarterly EPS earnings growth|KROS - Quarterly EPS earnings growth|Arcturus Therapeutics (ARCT) - Year-over-year earnings per share growth for the last twelve months|etonpharma.com - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Kamada|Year-over-year net earnings per share growth for the last 12 months Fulcrum Therapeutics Inc (FULC)|Quarterly EPS earnings growth ABEO|Quarterly EPS earnings growth mereobiopharma.com (MREO)|Year-over-year earnings per share growth for the last twelve months Pliant Therapeutics, Inc. PLRX|APLT (Applied Therapeutics Inc.) - Year-over-year net earnings per share trend for the last twelve months|RNTX - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months GELS (Gelteq Limited)|aytubio.com (AYTU) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Chemomab Therapeutics Ltd. (CMMB)|Year-over-year net earnings per share growth for the last 12 months SRXH|PLRZ (Polyrizon Ltd.) - Year-over-year earnings per share growth rate for the last twelve months|Quarterly EPS earnings growth AEZS|Quarterly EPS earnings growth Cyclo Therapeutics Inc. (CYTH)|Year-over-year earnings per share growth for the last twelve months Inozyme Pharma INZY|Reneo Pharmaceuticals, Inc - Year-over-year earnings per share growth for the last twelve months|COSCIENS Biopharma Inc. - Quarterly EPS earnings growth